Form 4: Phreesia SVP David Linetsky Sells Shares to Cover Tax Obligations and Under 10b5-1 Plan

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares of common stock to cover tax obligations and pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 16, 2025, David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 2,011 shares of common stock at a weighted average price of $23.8072 per share.
• These shares were sold to cover tax withholding obligations related to the settlement of restricted stock units.
• Additionally, Linetsky sold 2,488 shares of common stock at $23.66 per share under a pre-arranged Rule 10b5-1 trading plan adopted on January 15, 2025.
• Following these transactions, Linetsky directly owns 217,239 shares and indirectly owns 9,012 shares through his spouse.

Sentiment

Score: 5

Explanation: The document reports routine stock sales by an executive, primarily for tax obligations and under a pre-existing trading plan. This is a neutral event and doesn't indicate a significant positive or negative outlook for the company.

Industry Context

Executive stock sales are a common occurrence, especially to cover tax obligations related to equity compensation. The use of a 10b5-1 plan indicates a pre-arranged strategy to avoid accusations of insider trading.

Stakeholder Impact

• The stock sales could have a minor, temporary impact on the stock price, but the transactions are not expected to significantly affect stakeholders.

Key Dates

Keywords

Phreesia, David Linetsky, stock sale, Form 4, Rule 10b5-1, insider trading, tax obligations, restricted stock units